Francisco Diaz-Mitoma
2019
In 2019, Francisco Diaz-Mitoma earned a total compensation of $917.2K as Chief Medical Officer at VBI Vaccines, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $96,071 |
|---|---|
| Option Awards | $429,000 |
| Salary | $392,127 |
| Total | $917,198 |
Diaz-Mitoma received $429K in option awards, accounting for 47% of the total pay in 2019.
Diaz-Mitoma also received $96.1K in bonus and $392.1K in salary.
Rankings
In 2019, Francisco Diaz-Mitoma's compensation ranked 9,670th out of 13,971 executives tracked by ExecPay. In other words, Diaz-Mitoma earned more than 30.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,670 out of 13,971 | 31st |
Division Manufacturing | 3,891 out of 5,695 | 32nd |
Major group Chemicals And Allied Products | 1,479 out of 2,194 | 33rd |
Industry group Drugs | 1,263 out of 1,880 | 33rd |
Industry Pharmaceutical Preparations | 937 out of 1,392 | 33rd |
Source: SEC filing on April 28, 2020.
Diaz-Mitoma's colleagues
We found two more compensation records of executives who worked with Francisco Diaz-Mitoma at VBI Vaccines in 2019.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019